{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fidpodcast.simplecast.com%2Fepisodes%2Faudio-recap-managing-art-failure-lw5Ky6TF","width":444,"version":"1.0","type":"rich","title":"Managing ART Failure: Answering the Questions","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/26d7523c-7315-48a0-9da6-29d252d3ce90/91664e4f-2805-44ee-a83b-f513496eed9c/optimal-trt-prevention-prp4585-pod8-3000x3000.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/ad4b5ad4-e01b-455a-bb40-cffac109e8ce\" height=\"200\" width=\"100%\" title=\"Managing ART Failure: Answering the Questions\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Hear from expert faculty as they discuss questions about managing ART failure including guideline definitions and recommendations, the likelihood of failure with resistance with first-line ART regimens, drug‒drug interaction considerations, and more."}